According to Allergy Therapeutics's latest financial reports the company's total liabilities are A$0.12 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2024-06-30 | A$0.11 B | -6.29% |
2023-06-30 | A$0.12 B | 98.76% |
2022-06-30 | A$62.03 M | -14.87% |
2021-06-30 | A$72.87 M | -4.16% |
2020-06-30 | A$76.03 M | 35.93% |
2019-06-30 | A$55.93 M | 12.03% |
2018-06-30 | A$49.92 M | 8.35% |
2017-06-30 | A$46.08 M | -3.01% |
2016-06-30 | A$47.5 M | 42.77% |
2015-06-30 | A$33.27 M | 38.08% |
2014-06-30 | A$24.09 M | 1.3% |
2013-06-30 | A$23.78 M | 18% |
2012-06-30 | A$20.16 M | -52.92% |
2011-06-30 | A$42.82 M | -4.45% |
2010-06-30 | A$44.81 M | -51.52% |
2009-06-30 | A$92.43 M | 28.89% |
2008-06-30 | A$71.71 M | 96.98% |
2007-06-30 | A$36.4 M | 182.44% |
2006-06-30 | A$12.88 M | -16.46% |
2005-06-30 | A$15.42 M | 40.79% |
2004-06-30 | A$10.95 M | -20.76% |
2003-06-30 | A$13.82 M | -64.01% |
2002-06-30 | A$38.42 M |